Abstract A082: Contribution of health insurance to racial and ethnic disparities in advanced stage diagnosis of 10 cancers

Abstract For many cancer sites, it is unclear to what extent differences in health insurance coverage contribute to racial and ethnic disparities in stage III-IV diagnoses. Using the National Cancer Database (1,893,026 patients aged 18-64 years, diagnosed between 2013-2019), we investigated a potential mediating role of health insurance (privately insured vs. uninsured) in explaining racial and ethnic disparities in stage at diagnosis of 10 cancers (i.e., breast, prostate, colorectal, lung, cervical, uterine, bladder, head and neck, skin melanoma), detectable early through screening, physical examination, or clinical symptoms. The analyses provided evidence of mediation of non-Hispanic Black vs. White disparities in eight cancers (range of proportions mediated: 4.5%-29.1%); Hispanic vs. non-Hispanic White disparities in six cancers (13.2%- 68.8%); non-Hispanic Asian/Pacific Islander vs. White disparities in three cancers (5.8%- 11.3%). To summarize, health insurance accounts for a considerable proportion of the racial and ethnic disparities in stage III-IV diagnoses across a wide range of cancers. Citation Format: Parichoy Pal Choudhury, Helmneh M. Sineshaw, Rachel A. Freedman, Michael T. Halpern, Leticia Nogueira, Ahmedin Jemal, Farhad Islami. Contribution of health insurance to racial and ethnic disparities in advanced stage diagnosis of 10 cancers [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A082.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2024-09-21
DOI
https://doi.org/10.1158/1538-7755.disp24-a082
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A082: Contribution of health insurance to racial and ethnic disparities in advanced stage diagnosis of 10 cancers

Ahmedin Jemal, Farhad Islami, Helmneh M. Sineshaw, Parichoy Pal Choudhury et al.
Cancer Epidemiology Biomarkers & Prevention
Economic and Financial Impacts of Cancer
article

Abstract A082: Contribution of health insurance to racial and ethnic disparities in advanced stage diagnosis of 10 cancers

Ahmedin Jemal, Farhad Islami, Helmneh M. Sineshaw, Parichoy Pal Choudhury, Michael T. Halpern, Letícia Nogueira, Rachel A. Freedman
article en

Abstract

Abstract For many cancer sites, it is unclear to what extent differences in health insurance coverage contribute to racial and ethnic disparities in stage III-IV diagnoses. Using the National Cancer Database (1,893,026 patients aged 18-64 years, diagnosed between 2013-2019), we investigated a potential mediating role of health insurance (privately insured vs. uninsured) in explaining racial and ethnic disparities in stage at diagnosis of 10 cancers (i.e., breast, prostate, colorectal, lung, cervical, uterine, bladder, head and neck, skin melanoma), detectable early through screening, physical examination, or clinical symptoms. The analyses provided evidence of mediation of non-Hispanic Black vs. White disparities in eight cancers (range of proportions mediated: 4.5%-29.1%); Hispanic vs. non-Hispanic White disparities in six cancers (13.2%- 68.8%); non-Hispanic Asian/Pacific Islander vs. White disparities in three cancers (5.8%- 11.3%). To summarize, health insurance accounts for a considerable proportion of the racial and ethnic disparities in stage III-IV diagnoses across a wide range of cancers. Citation Format: Parichoy Pal Choudhury, Helmneh M. Sineshaw, Rachel A. Freedman, Michael T. Halpern, Leticia Nogueira, Ahmedin Jemal, Farhad Islami. Contribution of health insurance to racial and ethnic disparities in advanced stage diagnosis of 10 cancers [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A082.

Cancer Epidemiology Biomarkers & PreventionVol. 33(9_Supplement)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), American Cancer Society (US), Dana-Farber Cancer Institute (US), National Cancer Institute (US)
Openalex Percentile: Top 80%
Economic and Financial Impacts of Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.